Please see the letter below registering a complaint with the U.S. Department of Justice. You may contact the Citizen Complaint Center at the following email address: antitrust.complaints@usdoj.gov --------- Original Message ---------- From: Carl Tuttle To: antitrust.complaints@usdoj.gov Cc: ddutko@hanszenlaporte.com Date: December 21, 2017 at 1:28 PM Subject: Racketeering antitrust lawsuit against the Infectious Diseases Society of America Dec 21, 2017 Citizen Complaint Center Antitrust Division 950 Pennsylvania Ave., NW Room 3322 Washington, DC 20530 E-mail: antitrust.complaints@usdoj.gov To whom it may concern, From the following article: Finally, a Lyme disease antitrust suit http://www.capecodtimes.com/opinion/20171221/finally-lyme-disease-antitrust-suit Dec 21, 2017 Summary: Recently, 28 patients filed a federal racketeering antitrust lawsuit against the Infectious Diseases Society of America, or IDSA, eight health insurance companies and seven medical doctors. The suit claims health insurers are denying coverage using bogus guidelines established by the doctors, who were paid consultants, to falsely say the disease can be cured with a month of antibiotics and that longer-term treatment is unnecessary and potentially harmful. The suit alleges that in the 1990s, the insurance industry decided that treatment of Lyme disease was too expensive and “red-flagged” it, making a concerted effort to deny coverage for treatment of the disease. It claims the defendant insurers enlisted the help of doctors who were researching, not treating, Lyme disease, paid them large fees and together developed arbitrary guidelines for testing the disease. Once these arbitrary guidelines were decided, the suit claims, the insurers denied coverage for patients if they did not meet their new stringent Lyme disease testing protocols. Since most Lyme patients would not test positive under the new protocols, the insurers could deny coverage for many people suffering from Lyme disease. The plaintiffs claim that insurers, with the help of the paid IDSA panelists, decided that long-term antibiotic treatment was not necessary and all Lyme disease patients could be cured in less than a month. By August of 1992, the defendant insurers had imposed an intravenous antibiotic limit of 28 days. You can read the court document here: https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf Lead attorney: Eugene Egdorf of Shrader & Associates in Houston Texas ______________________ To the Department of Justice Antitrust Division; It is believed that members of the Centers for Disease Control aligned themselves with the defendants of this racketeering lawsuit to deny chronic Lyme disease as evidence of persistent infection has been suppressed for 26 years outlined in the attached letter addressed to Brenda Fitzgerald, MD Director of the CDC. Letter to Brenda Fitzgerald, MD Director of the CDC: https://www.dropbox.com/s/xaul84dqmqgbre0/Brenda%20Fitzgerald%20MD%20Director%20CDC.docx?dl=0 Laboratory and autopsy reports provide evidence that Lyme is not easily treated with the mandated one-size-fits-all IDSA treatment guideline but the CDC ignored this evidence colluding with the IDSA and seven defendants of the racketeering lawsuit. Money in the form of research grants was paid by the CDC to Dr. Gary Wormser of New York Medical College to downplay the severity of Lyme disease (excluding the sickest of patients and suppressing evidence of persistent infection after antibiotic treatment) while he focused on the acute stage of disease comparing Lyme to the aches and pains of daily living. 1.5 million dollars was given to Wormser for his junk science to support his racketeering scheme. Title: SUBJECTIVE SYMPTOMS AFTER TREATMENT OF LYME DISEASE Project Information: https://projectreporter.nih.gov/project_info_description.cfm?aid=8707215&icde=37403897 Contact PI / Project Leader: WORMSER, GARY P Awardee Organization: NEW YORK MEDICAL COLLEGE Project numbers: 5R01CK000152-05 $300,000 5R01CK000152-04 $300,000 5R01CK000152-03 $300,000 5R01CK000152-02 $300,000 1R01CK000152-01 $300,000 Most research grants are issued by the NIH but in this particular case funds came directly from the CDC as identified in the attached letter to the Office of Research Integrity. Letter to the Office of Research Integrity: https://www.dropbox.com/s/94jv3w2hb0z9lv7/Email%20sent%20to%20the%20Office%20of%20Research%20Integrity.docx?dl=0 Individuals of the CDC who have been interwoven into in this Lyme disease racketeering scheme: David Dennis C. Ben Beard Barbara Johnson Paul Mead Lyle Petersen Joseph Breen Beth P. Bell Marty Schriefer Claudia Molins Christina Nelson Former NIH Lyme Program Officers: Phillip Baker Edward McSweegan From the US DOJ Website: https://www.justice.gov/usam/criminal-resource-manual-109-rico-charges 109. RICO Charges “The RICO statute expressly states that it is unlawful for any person to conspire to violate any of the subsections of 18 U.S.C.A. § 1962. The government need not prove that the defendant agreed with every other conspirator, knew all of the other conspirators, or had full knowledge of all the details of the conspiracy. Delano, 825 F. Supp. at 542. All that must be shown is: (1) that the defendant agreed to commit the substantive racketeering offense through agreeing to participate in two racketeering acts; (2) that he knew the general status of the conspiracy; and (3) that he knew the conspiracy extended beyond his individual role. United States v. Rastelli, 870 F. 2d 822, 828 (2d Cir.), cert. denied, 493 U.S. 982, 110 S. Ct. 515, 107 L. Ed. 2d 516 (1989).” ______________ This crime to defraud the American public (while using taxpayer dollars) has caused untold pain and suffering from an infection capable of destroying lives. The fraudulent misclassification of Lyme as a simple nuisance disease has left hundreds of thousands chronically ill while the focus was to discredit the sick and disabled. We have lost three decades to this racketeering activity while the attention and research dollars should have been used to find new approaches to fight this antibiotic resistant/tolerant superbug. Please take this complaint against members of the CDC and NIH seriously as an investigation into the deliberate mishandling of Lyme disease is long overdue. Respectfully submitted, Carl Tuttle Independent Researcher Lyme Endemic Hudson, NH Cc: Daniel R. Dutko, HANSZEN LAPORTE